Contact Stock Affairs

فارسی
Contact Us
Contact Us

Gallery
Contact Us
Phone Number:+9821-88201940-3(144)
Fax: +9821-88201940
Email: info(at)alborzinvest.ir
Subsidiaries
Sobhan Pharmaceutical

Sobhan Darou

Alborz Darou

Iran Darou

KBC
Pakhsh Alborz

Sobhan Oncology

Etela Alborz

Alborz Bulk

Tolid Darou
Subsidiaries
Alborz Investment as a specialized pharmaceutical holding in the country, has been able to gain a good position in the pharmaceutical industry and has ten subsidiaries.
Shareholders’ Affairs
Stockholders’ Portal

FAQ

Contact Stock Affairs
Shareholders’ Affairs
Phone : +98 21 88201940-3

FAX :+98 21 88201940-3

Email:stock@alborzinvest.ir
Capital Market
Daily Reports of Market

Analytical Reports

Alborz in Bourse
Capital Market
Alborz investment group as one of the biggest pharmaceutical holding which holds more than 13 percent of pharmaceutical market is renowned as a knowledge-based and pioneer enterprise in producing active pharmaceutical ingredient, commercial affairs, final product, distributing and research in the field of human-health.
Shareholding Relations
Financial Statements

Alborz Stock Price Trend

Shareholders’ Combination

Specialized Committees
Shareholding Relations
Alborz investment group as one of the biggest pharmaceutical holding which holds more than 13 percent of pharmaceutical market is renowned as a knowledge-based and pioneer enterprise in producing active pharmaceutical ingredient, commercial affairs, final product, distributing and research in the field of human-health.
About Us
History

Market Positioning

Organizational Structure

Code of ethics
Vision & Mission

Introduction Catalog

Board of Directors

The Company's Capital
About Us
Alborz Investment Co. (Public Company) was primarily founded under the name of “Yekdel” on December, 24th, of 1966 with the registration No
Home Page

Contact form

Phone Number +98 2188480161

Fax +98 2188870881

Email stock@alborzinvest.ir

Address : No.5, Aviz Alley, Alvand Street, Arzhantin Square, Tehran, Iran

Phone Number : +9821-88201940 – 3

Email : info@alborzinvest.ir

فارسی
Contact Us
Contact Us

Gallery
Contact Us
Phone Number:+9821-88201940-3(144)
Fax: +9821-88201940
Email: info(at)alborzinvest.ir
Subsidiaries
Sobhan Pharmaceutical

Sobhan Darou

Alborz Darou

Iran Darou

KBC
Pakhsh Alborz

Sobhan Oncology

Etela Alborz

Alborz Bulk

Tolid Darou
Subsidiaries
Alborz Investment as a specialized pharmaceutical holding in the country, has been able to gain a good position in the pharmaceutical industry and has ten subsidiaries.
Shareholders’ Affairs
Stockholders’ Portal

FAQ

Contact Stock Affairs
Shareholders’ Affairs
Phone : +98 21 88201940-3

FAX :+98 21 88201940-3

Email:stock@alborzinvest.ir
Capital Market
Daily Reports of Market

Analytical Reports

Alborz in Bourse
Capital Market
Alborz investment group as one of the biggest pharmaceutical holding which holds more than 13 percent of pharmaceutical market is renowned as a knowledge-based and pioneer enterprise in producing active pharmaceutical ingredient, commercial affairs, final product, distributing and research in the field of human-health.
Shareholding Relations
Financial Statements

Alborz Stock Price Trend

Shareholders’ Combination

Specialized Committees
Shareholding Relations
Alborz investment group as one of the biggest pharmaceutical holding which holds more than 13 percent of pharmaceutical market is renowned as a knowledge-based and pioneer enterprise in producing active pharmaceutical ingredient, commercial affairs, final product, distributing and research in the field of human-health.
About Us
History

Market Positioning

Organizational Structure

Code of ethics
Vision & Mission

Introduction Catalog

Board of Directors

The Company's Capital
About Us
Alborz Investment Co. (Public Company) was primarily founded under the name of “Yekdel” on December, 24th, of 1966 with the registration No
Home Page

Contact form

Contact Stock Affairs

Phone Number +98 2188480161

Fax +98 2188870881

Email stock@alborzinvest.ir

Subsidiaries

Contact Us

Subsidiaries

Shareholders’ Affairs

Capital Market

Shareholding Relations

About Us